LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Tofacitinib for the treatment of primary cutaneous amyloidosis: A case report

Photo from wikipedia

Dear Editor, Primary cutaneous amyloidosis (PCA) is featured by the deposition of amyloid within the papillary dermis without involving other organs. PCA is common in Asians who suffer plaque on… Click to show full abstract

Dear Editor, Primary cutaneous amyloidosis (PCA) is featured by the deposition of amyloid within the papillary dermis without involving other organs. PCA is common in Asians who suffer plaque on the extensor surfaces of the extremities and continuous pruritic. Although several therapies of LA were suggested, none of the treatment modalities has been proven to be effective and curative. Both topical therapies for PCA including corticosteroids, calcipotriene, UVB (Ultraviolet Radiation B), or PUVA (Psoralen and Ultraviolet Radiation A) phototherapy, and Carbon Dioxide Laser, and systemic therapies

Keywords: treatment primary; primary cutaneous; cutaneous amyloidosis; tofacitinib treatment

Journal Title: Dermatologic Therapy
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.